Primary research for the answer-engine era, our most-cited piece.
Five constraint numbers locked before build. Six stages from discovery to hand-off.
Resourcifi builds healthcare AI solutions for provider, payer, and life-sciences software, clinical copilots, retrieval, and agents shipped inside your HIPAA and BAA boundary behind evaluations, guardrails, and cost controls. As a healthcare AI development company, we treat the gap between a working demo and a production feature as the real engineering problem. About a third of our AI work is Production Recovery, fixing AI features other vendors abandoned in proof of concept.
A clinical AI feature is only as safe as what it retrieves, so we build the data layer first.
The best clinical AI feels native, streams in real time, and surfaces inside the EHR.
Real clinical automation chains tools and decisions, so we build approvals and limits in from the start.
Production-First AI means an eval gate, full tracing, and a deploy that blocks on a regression.
Shipping AI in healthcare means defending against PHI leaks, prompt injection, and unsafe output.
Healthcare AI solutions are clinical and operational software that put models to work on real patient and payer data inside a HIPAA-compliant boundary, things like documentation copilots, retrieval over the EHR, claims automation, and decision support, shipped behind evaluations and guardrails rather than left in a demo. The AI in healthcare market is projected to reach USD 187.7 billion by 2030, growing at a 38.5% CAGR, per Grand View Research (2025), yet most features do not fail on the demo, they fail on the way to production. A serious partner closes that gap on purpose. First, retrieval is engineered before the prompt: clean ingestion from EHRs and clinical documents, embeddings, hybrid search, and rerankers, with PHI scoped inside the BAA boundary so no record reaches a model provider that is not covered. Second, quality is measured, not asserted. We build a clinician-reviewed and LLM-judge evaluation harness and wire it into CI/CD, so a change that regresses accuracy or safety is blocked before it reaches a patient, which is exactly why so many healthcare AI projects stall after the proof of concept. Third, the feature is defended and accounted for: prompt-injection guardrails, PHI redaction, full tracing of every prompt and tool call, and hard cost and latency budgets, so the AI keeps its quality and its margins under real load. That is what Production-First AI means, and it is decided in the architecture long before launch.
Documentation drafting, summarization, and Q&A surfaced inside the EHR via SMART-on-FHIR, built to a sub-second first-token budget.
Metric: accept rate →Early signs of clinical deterioration from vitals and labs via risk-scoring models, with alerts routed through existing messaging.
Metric: time to alert →Adjudication automation and anomaly scoring with SHAP explanations generated for the human-review path.
Async, low-latency scoring →Retrieval over PubMed, ClinicalTrials.gov, and internal research, with citations and tenant-scoped indexes.
Metric: answer quality →Scheduling, medication reminders, and post-care feedback on a guarded LLM stack with PHI redaction at ingress.
Metric: deflection + CSAT →Forecast patient volumes, manage ICU capacity, and optimize staffing, backtested against the incumbent.
Metric: forecast error →Predict binding and optimize targets with RDKit and DeepChem, model structure, and simulate trials.
Research workflows →Match patients to therapies via models over genomic, clinical, and lifestyle data, with per-patient cohort retrieval.
Cohort retrieval →Draft structured visit notes from ambient audio for clinician sign-off inside the EHR, cutting documentation time.
Metric: note acceptance →The biggest downstream decision is where inference happens relative to the BAA boundary. Independent of that choice, every deployment ships with the same five-number constraint set, defined before code is written: p95 latency, cost-per-call, throughput floor, accuracy floor, and recovery time objective.
Route PHI to HIPAA-eligible offerings on AWS Bedrock, Azure OpenAI, or GCP Vertex under signed BAAs. Cheaper to run, simpler to evaluate, and the data never leaves a covered provider.
Most healthcare features →Run Safe Harbor or Expert Determination before the request leaves the boundary, so the model only ever sees de-identified text. Good when a provider is not BAA-covered for a use case.
Safe Harbor / Expert Determination →Self-host Llama or Mistral on vLLM inside your VPC or on-prem for air-gapped or data-residency-bound workloads. The operational overhead is real; used where policy requires it.
vLLM, on-prem →We model gross margin per AI feature first. A feature that prices into negative contribution margin at expected clinical volume gets re-scoped, not built. This is advisory work on how you fund or charge for the feature; it carries no Resourcifi service prices.
Works when AI usage roughly tracks provider seats. Requires a predictable cost-per-seat, which forces tight per-call ceilings.
Predictable usage →Charge or budget per encounter, claim, or document processed. Needs in-product usage visibility so a department never gets a surprise bill.
Concentrated usage →A workable floor sits inside the seat or contract price; heavy use is metered. Aligns gross margin with usage without scaring off light adopters.
Maturing programs →Healthcare AI touches PHI, third-party models, and clinical decisions, so security and governance are part of the build from the first sprint, never a checklist at the end.
Every model provider in the inference path must be BAA-covered, or PHI is de-identified before it leaves the boundary.
The worst healthcare AI failure is PHI reaching a provider that never signed a BAA.
How we build to it: we sign BAAs with covered entities and execute them with every provider in the path, route PHI to HIPAA-eligible offerings on Bedrock, Azure OpenAI, and Vertex, and where a provider is not covered we de-identify at the edge via Safe Harbor or Expert Determination. PHI flow is documented per use case.
The AI serving layer has to slot into your existing HITRUST and SOC 2 program, not break it.
Procurement reviews the AI feature as part of the security review, asking about data flows, retention, and sub-processors.
How we build to it: we design the serving layer to fit inside your existing boundary, with sub-processors inventoried, DPAs in place, and audit logging of prompts and retrievals.
When the use case touches diagnosis, treatment, or trial endpoints, the eval bar and audit trail change.
SaMD classification reshapes the evidence a feature has to produce before it ships.
How we build to it: we flag SaMD scope in week one, design the eval suite and audit trail for FDA-grade review, and keep electronic records and signatures aligned with 21 CFR Part 11 where it applies.
Health data is special-category data, and EU-patient data must be processable inside EU regions.
Most major model providers now offer regional inference, so EU-patient data can be processed inside EU regions.
How we build to it: region-aware routing of inference, processor agreements in place, and audit logs that prove where each request was processed.
Ingested patient and document content can carry adversarial instructions targeting your model.
We treat ingested documents, notes, and messages as untrusted.
How we build to it: a four-layer governance stack (model guardrails, validation pipelines, auto-retraining, and real-time observability) with named tools: Guardrails.ai, LangSmith, Weights & Biases, Evidently AI, Prometheus and Grafana. Ingested content passes validation before it can influence an action.
Every production deployment ships against five numbers defined before code is written.
Quality, cost, and uptime are commitments, not hopes, so we make them numeric and instrument them.
How we build to it: p95 latency target, cost-per-call ceiling, throughput floor, accuracy floor on a clinician-reviewed reference dataset, and a recovery time objective, each instrumented from day one. These five numbers are the contract the feature has to meet to ship.
We engineer to each of these. We do not claim certification on your behalf.
For context on why this matters: Gartner projects that at least 30% of generative AI projects will be abandoned after proof of concept by the end of 2025, citing poor data quality, weak controls, and unclear value, per Gartner.
We map the use case, the data it depends on, and the HIPAA, BAA, and PHI-flow surface, then set the deployment constraints first: the p95 latency target, the cost-per-call ceiling, and the accuracy floor, with a line-by-line estimate before you commit.
A senior AI engineer, named for the engagement before contracts are signed, assesses feasibility, the model strategy, the BAA scope, the EHR integration footprint, and the clinician-in-the-loop review, deciding build-versus-buy per component so the economics are clear before any code.
We sequence the features, each scoped and instrumented individually with its own latency budget, eval metric, and cost ceiling, so the 12-month plan is a set of shippable, measurable units rather than one big bet.
The feature ships in milestones wired into your EHR and APIs over FHIR R4 and HL7 v2, and we stand up the three-layer eval suite as a first-class artifact: a clinician-reviewed reference dataset, an adversarial set covering prompt injection and malformed FHIR, and a regression set where every incident becomes a permanent entry.
The eval suite runs on every deploy and on a schedule against the live model behind a feature flag, with tracing, the four-layer governance stack, and per-feature cost budgets switched on, so the first production deploy is observable and reversible.
We watch quality, latency, and spend on live traffic, fold drift and incidents back into the evals, and engineer the hand-off so your in-house team owns the model selection, the eval suite, the dashboards, and the run-book at the end.
Frontier models from Anthropic Claude, OpenAI, and Google Gemini, plus open-weight Llama and Mistral self-hosted on vLLM where data residency or BAA scope demands it, with routing and caching to balance quality against latency and spend.
Claude, OpenAI, Llama, vLLM →Vector and hybrid search on pgvector, Pinecone, or Weaviate, with rerankers and ingestion pipelines, plus FHIR R4, HL7 v2, SMART-on-FHIR, and Epic and Oracle Health (Cerner) clients so a feature reaches the clinician inside the system they use.
pgvector, FHIR, HL7 v2 →Tool and function calling, multi-step agents and workflows with LangGraph or custom orchestration, queues and event streams, and clinician-in-the-loop approval steps for anything consequential.
Tool calling, LangGraph, queues →A clinician-reviewed and LLM-judge eval harness wired into CI/CD, with a four-layer governance stack of named tools: Guardrails.ai and Presidio for PHI and output validation, LangSmith for tracing, Weights & Biases for eval tracking, Evidently AI for drift, and Prometheus and Grafana for latency and cost, on AWS, GCP, or Azure.
Guardrails.ai, Presidio, LangSmith →A discovery call, then an AI assessment where a senior AI engineer is named for the engagement, not a faceless team, and which covers BAA scope, PHI flow, and EHR integration, then roadmap, build, and deploy.
One senior AI engineer to prove a single feature meets its deployment constraint set inside your HIPAA boundary.
Prove one feature →A small pod for a full feature ship, including evals, observability, EHR integration, and hand-off.
Ship to production →Multi-feature roadmaps and ongoing operate-mode work for teams shipping clinical AI continuously.
Roadmaps and operate →We do not publish a named healthcare AI case study we cannot stand behind, so we will not invent one. What we can stand behind is the record: 200+ in-house experts across AI, data, and full-stack, 600+ projects delivered since 2017, a 95% repeat-client rate, and a 90-day median to a working build. A meaningful share of that work is Production Recovery, rebuilding AI features other vendors abandoned in proof of concept, where the demo worked on a curated dataset and the production version degraded against a live EHR or surfaced a PHI flow nobody scoped. The pattern holds: we scope the data, the eval criteria, and the compliance surface first, deliver milestones you can see working, and ship behind the five-number constraint set so it holds under real traffic.
The questions provider, payer, and life-sciences leaders ask us on the first scoping call, answered straight.
Median is 90 days for a single well-scoped feature with clear deployment constraints (p95 latency, cost-per-call, accuracy floor); pilots can prove a feature in 6 to 8 weeks. The longest pole is almost never the model, it is EHR integration, clinician-in-the-loop review, and BAA scope with your security team. We do not ship a healthcare AI feature without evals running in CI.
Yes. We sign BAAs with covered entities and execute them with every model provider in the inference path. PHI either stays inside the BAA boundary end to end, or it is de-identified at the edge via Safe Harbor or Expert Determination before it reaches a model. PHI flow is documented per use case in the AI Assessment, with audit logs on every retrieval.
Through FHIR R4, HL7 v2, and SMART-on-FHIR, with Epic and Oracle Health (Cerner) API clients and Redox where it fits. A feature only matters if it reaches a clinician inside the system they already use, so we scope the integration footprint in the AI Assessment and treat it as the longest pole, not an afterthought.
When the use case touches diagnosis, treatment decisions, or trial endpoints, SaMD classification changes the eval bar and the audit trail. We flag this in week one, design the eval suite and electronic records for FDA-grade review, and keep signatures and records aligned with 21 CFR Part 11 where it applies. We do not claim a classification on your behalf.
A three-layer eval suite. A clinician-reviewed reference dataset of 100 to 500 representative cases inside the BAA boundary, scored on the metric that matters for the feature. An adversarial set covering prompt injection, malformed FHIR, and edge-case ICD-10. And a regression set where every production incident becomes a permanent eval entry. The suite runs on every deploy and on a schedule behind feature flags.
We treat ingested notes, documents, and messages as untrusted and run them through a four-layer governance stack: model guardrails (Guardrails.ai and Presidio), validation pipelines (schema validation on structured output), auto-retraining (incidents become regression evals), and real-time observability (LangSmith, Evidently AI, Weights and Biases, Prometheus and Grafana). Ingested content passes validation before it can influence an action.
We design for hand-off from week one. Your in-house team owns the model selection, the eval suite, the observability dashboards, and the run-book at the end of the engagement, and we document the deployment constraint set, the eval methodology, the fallback strategy, the security checklist built to your HIPAA boundary, and the cost model, with paired on-call before close. A meaningful share of our AI work is recovery on systems where this hand-off was never engineered.
AI features built inside your existing healthcare software, with evals and observability wired in from day one.
AI application development → AI agent developmentMulti-step, tool-using agents wired to your systems with clinician-in-the-loop approval and the governance stack.
AI agent development → RAG developmentRetrieval over EHRs and clinical literature with PHI scoped inside the boundary and audit logs on every inference.
RAG development → Custom LLM developmentDomain adapters or fine-tunes where the clinical vocabulary and the economics justify going beyond a shared base model.
Custom LLM development → AI workflow automationClaims, scheduling, and documentation automation that runs async and cost-efficiently inside your boundary.
AI workflow automation → AI consultingA named senior engineer to scope the use case, the BAA and PHI-flow surface, and the deployment constraints before you commit to a build.
AI consulting →We use cookies to analyze traffic and improve your experience. See our Privacy Policy.
